What is the efficacy of inorganic nitrate in the prevention of contrast-induced nephropathy (CIN) in high-risk patients presenting with acute coronary syndromes? Get the answer here: bit.ly/4aOUvMG #cvACS

Had this exact discussion on rounds today!

Ticagrelor, when compared to placebo (in patients with #diabetes and #atherosclerosis) decreases limb events, but with an increased risk of bleeding. Read the journal scan to learn more: bit.ly/4bcFMuP #cvPAD #cvCAD

It's time for another #TeachingTuesday!! Check out this amazing infographic on Antithrombotic Management After TAVR created by the University of Maryland's PGY-2 Cardiology Pharmacy Resident, Tiffany Gardner, PharmD! 🫀

Many congratulations to all on presenting innovative research on Post Graduation Recognition Day Lahey Hospital Lahey Hospital Department of Medicine Research A time to celebrate the incredible achievements of our talented trainees Special kudos to Rushin Patel, MD Rushin Patel MD for the first 🏆 in oral

*Breaking* P3 #FINEARTSHF meets its primary endpoint (CVd+total HF events)! Non-steroidal MRA finerenone "demonstrates definitive CV benefits" in HFmrEF & HFpEF Looking forward to presenting full results at #ESCCongress alongside scottdavidsolomon @PSJhund bayer.com/media/en-us/fi…

New 2024 #ESCGuidelines on #Afib 🆕! Use the CHA2DS2-VA score (without Sc) #ESCCongress European Society of Cardiology

A single combined measure of hsCRP, LDL-C, and Lp(a) among initially healthy women was predictive of incident cardiovascular events over a 30-year period. All 3 biomarkers are modifiable thru either lifestyle or pharmacologic interventions #ESCCongress #cardiology #prevention

#FINEARTSHF HFmrEF/HFpEF population Finerenone vs placebo Reduced primary endpoint (CVD / HF events) Looking forward to ongoing subsequent trials and analyses.

when the team wants a bumex gtt after furosemide 40mg IVP x1

Do you speak ID? David Ha David Ha expertly translating cardiology topics to an ID audience at #IDWeek2024 #range

Routine Spironolactone in Acute Myocardial Infarction: NEJM 🥸 Great trials from #AHA24: @AHASc 😱 Summary 👇👇👇

Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia: NEJM 🥸 One of my friends said that #AHA24 brought a lot of enthusiasm back: AHA Science 😱 Catheter ablation for VT - it works: VANISH2 👇👇👇

BROOKLYN trial shows In pts with heterozygous familial hypercholesterolemia already on statins, novel CETP inhibitor obicetrapib reduces LDL-C by an add’l 40%. View slides here: clinicaltrialresults.org/dr-stephen-nic…

The wait is over! Here's a complete list of all 29 clinical trials from AHA 2024 published by AHA itself. Which one are you most excited about? #AHA2024 #Cardiology #ClinicalTrials #HeartHealth #Medicine #AHA #ACC #cardiotwitter #CardioEd

We are excited to announce a new advanced endovascular interventional program starting this July 2025. It is a unique program with shared training between Interventional cardiology and vascular surgery! Contact me at [email protected] or DM me to learn more!

Outpatient loading of sotalol through a pharmacist-led, protocol-driven antiarrhythmic clinic is safe & feasible w/ high adherence rates using personal remote ECG recordings. Read the journal scan to learn more: bit.ly/4g6ANOH #JACCCEP

From JAMA: In patients needing coagulation factor replacement after cardiac surgery, prothrombin complex concentrate showed superior hemostatic effectiveness & fewer serious adverse events & acute kidney injuries compared to frozen plasma. #ACC25 ja.ma/3QPCkhM

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes: NEJM 🥸 Among persons with type 2 DM and ASCVD, CKD, or both, the use of oral semaglutide was associated with a significantly lower MACE 😱 Summary 👇👇👇

Looking forward to 2025-2027 outcome studies of #tirzepatide for #obesity related consequences in various populations Eli Lilly and Company Ref: tandfonline.com/doi/pdf/10.108…